MedTrace Logo

Cardioneuroablation for the Treatment of Vagally-mediated Atrial Fibrillation.

NCT05461859 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2023-11-27

No results posted yet for this study

Summary

Pulmonary vein isolation (PVI) is a cornerstone for catheter ablation of atrial fibrillation (AF), however, exact mechanisms of PVI efficacy remain debatable. It has been postulated that in patients with increased vagal tone AF can be treated by attenuation of parasympathetic drive to the heart using cardioneuroablation (CNA) by means of radiofrequency (RF) of the ganglionated plexi, however, data in literature and guidelines are lacking. The objective of this study is to examine the mid-term efficacy of RF-CNA targeting the right anterior ganglionated plexus (RAGP) in management of AF using right-atrial approach only.

Conditions

  • Atrial Fibrillation Paroxysmal

Interventions

PROCEDURE

Cardioneuroablation (CNA) of the right anterior ganglionated plexus (RAGP)

CNA of RAGP

Sponsors & Collaborators

  • St. Joseph's Centre, Poland

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-16
Primary Completion
2021-07-19
Completion
2023-01-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05461859 on ClinicalTrials.gov